BT-12Homo sapiens (Human)Cancer cell line

Also known as: BT12

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_M155
SpeciesHomo sapiens (Human)
Tissue SourceBrain, posterior fossa[UBERON:UBERON_0008788]

Donor Information

0
Age CategoryPediatric
SexFemale

Disease Information

DiseaseAtypical teratoid rhabdoid tumor
LineageCNS/Brain
SubtypeAtypical Teratoid/Rhabdoid Tumor
OncoTree CodeATRT

DepMap Information

Source TypeAcademic lab
Source IDACH-000160_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
11,13
D16S539
11,12
D18S51
13,14
D19S433
12,14
D21S11
29,33.2
D2S1338
23
D3S1358
15,16
D5S818
12
D7S820
9,12
D8S1179
13,15
FGA
22
TH01
7,9
TPOX
8,11
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

Reynolds C.P.

Pediatr. Blood Cancer 56:239-249(2011).

Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells.

Grotzer M.A.

Eur. J. Cancer 43:1581-1589(2007).